Skip to content

Upneeq

by Upneeq
Original price $240.00 - Original price $240.00
Original price
$240.00
$240.00 - $240.00
Current price $240.00

*In order to purchase this product you must also schedule a Virtual Consultation.

Imagine an EYE-OPENING Lift with a Daily Drop of Upneeq®

The only FDA-approved prescription eyedrop for acquired ptosis (low-lying lids) that lifts your upper eyelids to open your eyes.

This is the perfect combination product for any eye treatment (eye-lid surgery, laser treatments, thread lifts, fillers, plasma pen, chemical peels, AccuTite, Ultherapy, Renuvion,  etc.). 

This package contains 45 single-use containers in individual, child-resistant foil pouches . 

Customer Reviews

Based on 3 reviews Write a review

Eye-Opening Possibilities

Imagine an EYE-OPENING Lift with a Daily Drop of Upneeq® 
The only FDA-approved prescription eyedrop for acquired ptosis (low-lying lids) that lifts your upper eyelids to open your eyes

Unless otherwise indicated, all images depict actor portrayals

$240.00

ARE YOUR LOOKING A LITTLE TIRED?

Take a look in the mirror. What do you see?*

A

B

C

D

If you are bothered by your eyelid(s), talk to you healthcare provider to find out whether or not you have low-lying lids

This is for preliminary assessment only. Your healthcare provider can perform specific tests to accurately diagnose your type of low-lying lids.

You may have acquired ptosis.

Acquired ptosis (low-lying lids) is a common condition that:

  • Affects adults of all ages, but occurs more often with increased age
  • Usually occurs when the muscles in the eyelid stretch and weaken, causing the lid to droop
  • May be caused by other issues, such as cataract surgery, contact lens wear, or an underlying medical condition. 

How does acquired ptosis affect you?

In addition to affecting your appearance, low-lying eyelid(s) can also impact your eyesight by reducing your field of vision. Low-lying lids may lead to issues with:

Day-to-day functioning

  • Reading
  • Driving
  • Computer use

Appearance

  • Looking tired
  • Asymmetrical eyes
  • Cosmetic concerns

WARNINGS AND PRECAUTIONS

Ptosis may be associated with neurologic or orbital diseases such as stroke and/or cerebral aneurysm, Horner syndrome, myasthenia gravis, external ophthalmoplegia, orbital infection and orbital masses. Consideration should be given to these conditions in the presence of ptosis with decreased levator muscle function and/or other neurologic signs.

Real Results

Actual patient images courtesy of Dr. Raymond Douglas. Individual results may vary. Average upper eyelid lift with Upneeq in clinical trials was 1 mm.*2

*Two randomized, multicenter, double-masked, vehicle-controlled, Phase 3 studies compared once-daily Upneeq in 304 subjects with acquired blepharoptosis. Efficacy was assessed by points seen in the superior visual field using Leicester Peripheral Field Test (LPFT) and photographic measurement of Marginal Reflex Distance-1 (MRD-1). There was a statistically significant difference in mean change in the number of points seen in the superior visual field from baseline after instillation of Upneeq and vehicle, with significantly greater increases in the study eye of the Upneeq group evident at the 2-hour point and maintained at the 6-hour time point. Greater eyelid lift (increased MRD-1) was observed for the Upneeq group than the vehicle group on Day 1 at 6 hours post-dose and on Day 14 at 2 hours post-dose.

IMPORTANT SAFETY INFORMATION

UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is a prescription eyedrop used to treat low-lying lids (acquired blepharoptosis) in adults.

@jasonemermd

Follow Dr. Jason Emer on social to stay up to date on his latest in skincare and celebrity collaborations.